NCT01980329View on ClinicalTrials.gov

Polymorphic Effects of Cytochrome P450 3A5 on Pharmacokinetics of Maraviroc and Its Metabolites

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Cytochrome P450 CYP3A5 Enzyme PolymorphismHealthy SubjectsPharmacokinetics of Maraviroc
Interventions
DRUG

Maraviroc

Trial Locations (1)

21210

The Johns Hopkins University School of Medicine Division of Clinical Pharmacology, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT01980329 - Polymorphic Effects of Cytochrome P450 3A5 on Pharmacokinetics of Maraviroc and Its Metabolites | Biotech Hunter | Biotech Hunter